J.P. Morgan Maintains CME Group(CME.US) With Sell Rating, Raises Target Price to $209
Earnings Preview: CME Group to Report Financial Results Pre-market on October 23
CME Group Announces First Trades of CBL Australian Carbon Credit Unit (ACCU) Futures
Morgan Stanley Maintains CME Group(CME.US) With Hold Rating, Raises Target Price to $233
Is Now The Time To Put CME Group (NASDAQ:CME) On Your Watchlist?
Morgan Stanley Sticks to Its Hold Rating for CME Group (CME)
Morgan Stanley Raises Price Target on CME Group to $233 From $210, Keeps Equalweight Rating
CME Group Is Maintained at Outperform by Oppenheimer
Sector Update: Financial Stocks Edge Higher Pre-Bell Monday
Oppenheimer Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $245
Express News | CME Group Inc : TD Cowen Cuts Target Price to $219 From $221
CME Group International Average Daily Volume Reached New Record of 8.4 Million Contracts in Q3 2024
CPI Ahead, Fed Minutes, Delta Air Lines to Report - What's Moving Markets
Goldman Sachs Trims Price Target on CME to $197 From $198, Maintains Sell Rating
The central parity rate of the Renminbi is reported at 7.0568, up 141 basis points.
On October 9th, the central parity rate of the RMB was reported at 7.0568, up by 141 points, with the previous day's central parity rate at 7.0709. Ray Dalio, the founder of Bridgewater Associates, does not believe that the Federal Reserve will "significantly" cut interest rates. Billionaire investor Ray Dalio does not believe that the Fed will make another large rate cut after lowering rates by 0.5 percentage points last month. "The economy is currently in a relatively good balance," the Bridgewater Associates founder said on Tuesday at the Greenwich Economic Forum. The Federal Reserve cut rates for the first time in four years last month, but the subsequent strong jobs report provided room for the decision makers to slow down. Engaging in.
Today's Analyst Rating | UBS Cuts Its Price Target Cut on Alphabet-C to $187, Meta Platforms Price Target Raised to $665 by Guggenheim
Jefferies Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $254
Piper Sandler Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $240
CME Group Price Target Raised to $240 From $225 at Piper Sandler
Piper Sandler Sticks to Its Buy Rating for CME Group (CME)